Compare Ginkgo Bioworks Holdings Inc (DNA) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Tyson Foods, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Tyson Foods, Inc. trades at $53.43 (market cap $18.41B). The key difference: Tyson Foods, Inc. is far larger — about 24.1× Ginkgo Bioworks Holdings Inc's market cap, and Tyson Foods, Inc. pays a 3.9% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Tyson Foods, Inc. for 76 Days on average.
| DNA | TSN | |
|---|---|---|
Market Cap | $763.64M | $18.41B |
Volume | 3,204,177 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $15.83 | $68.75 |
52-Week Low | $5.48 | $50.47 |
Typical Hold Time | 7 Days | 76 Days |
Enterprise Value | $865.59M | $25.68B |
Dividend Yield | — | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day. The technical outlook is bullish based on moving averages, while oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with a negative net income margin of -219.6%. Recent news includes a partnership with TuneLab and a $17.5 million ARPA-H subcontract.
The outlook is challenged by persistent losses and negative cash flow, though strategic partnerships offer growth potential. Analyst sentiment is divided evenly between buy, hold, and sell ratings. Key risks include execution on profitability and high cash burn. The stock presents a speculative opportunity dependent on the company's ability to monetize its technology platform.
Tyson Foods (TSN) trades at $52.34, up 1.24% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported revenue of $54.44 billion in 2025, with a net income margin of 1.03%, while recent earnings show two beats and one miss. Analysts maintain a consensus buy rating with a $65.40 price target, but news highlights challenges in the beef segment and ongoing securities investigations.
The outlook for TSN is cautiously optimistic, supported by analyst confidence and dividend stability, but risks include margin pressure from beef losses, legal scrutiny, and volatile cash flows. The stock's valuation at a P/E of 32.31 appears elevated relative to modest profitability, requiring careful monitoring of execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
